Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 85 Lung Neoplasms 63 Carcinoma, Non-Small-Cell Lung 50 Neoplasm Metastasis 48 Breast Neoplasms 48 Glioma 41 Glioblastoma 38 Pancreatic Neoplasms 35 Multiple Myeloma 35 Brain Neoplasms 34 Carcinoma, Renal Cell 32 Lymphoma, Large B-Cell, Diffuse 29 Melanoma 28 Urinary Bladder Neoplasms 27 Colorectal Neoplasms 27 Squamous Cell Carcinoma of Head and Neck 25 Ovarian Neoplasms 24 Triple Negative Breast Neoplasms 21 Oropharyngeal Neoplasms 21 Carcinoma, Hepatocellular 21 Lymphoma 20 Mouth Neoplasms 18 Lymphoma, Follicular 18 Sarcoma 17 Fallopian Tube Neoplasms 16 Carcinoma 16 Laryngeal Neoplasms 15 Carcinoma, Transitional Cell 15 Astrocytoma 15 Lymphoma, Mantle-Cell 14

Interventions

Radiotherapy 1 Magnetic Resonance Spectroscopy 1 Holistic Health 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Arthritis × Magnetic Resonance Spectroscopy × 1 year × Clear all

NCT07284563 2025-12-16

Ultralow Dose PET Imaging for 18F-NaF Uptake

Nuclear Imaging Institute

Phase 2 Recruiting

Arthritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡